Diltiazem is a benzothiazepine-class calcium channel blocker widely indicated for the management of hypertension, chronic stable angina, and specific cardiac arrhythmias. By inhibiting the influx of calcium… Read more








![Chemical structure of rel-(2R,3S)-3-Hydroxy-2-(4-methoxyphenyl)-2,3-dihydrobenzo[b][1,4]thiazepin-4(5H)-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F30825-34-4-rel-2R3S-3-Hydroxy-2-4-methoxyphenyl-23-dihydrobenzob14thiazepin-45H-one.png&w=3840&q=75)
Diltiazem is a benzothiazepine-class calcium channel blocker widely indicated for the management of hypertension, chronic stable angina, and specific cardiac arrhythmias. By inhibiting the influx of calcium ions into vascular smooth muscle and cardiac cells, the drug effectively promotes vasodilation and reduces myocardial oxygen consumption. To support rigorous quality control and safety assessments, pharmaceutical laboratories rely on a comprehensive range of reference standards, including pharmacopeial and non-pharmacopeial impurities, synthetic intermediates, and degradation products. Furthermore, stable isotope labelled compounds function as essential internal standards for high-precision quantification in mass spectrometry and chromatography. These high-quality materials are fundamental for conducting thorough impurity profiling, analytical method validation, and forced degradation studies, ensuring that pharmaceutical preparations consistently meet established regulatory standards for safety and efficacy throughout the entire product lifecycle.